Biotech News 21 Sep 2024 Into the unknown: How quickly can vaccines be developed for Disease R&D frameworks are in place for the next pandemic-causing pathogen, but ways to derisk development are unclear. ‘Disease X’ is… Pantitra
Biotech News 05 Aug 2024 Nasal COVID-19 vaccine halts transmission Study in hamsters indicates vaccines targeting nose, mouth may be key to controlling spread of respiratory infections The lightning-fast development… Pantitra
Biotech News 12 Jul 2024 Scientists discover how to improve vaccine response to potentially deadly bacterium Researchers from Trinity College Dublin have taken a leap forward in understanding how we might fight back against the potentially… Pantitra
Biotech News 27 Jun 2024 Revolutionizing Vaccine Storage and Distribution with Innovative Solutions Vaccine storage and distribution innovations are crucial for ensuring vaccine efficacy, expanding accessibility, and enhancing real-time monitoring. March 06, 2024 - The… Pantitra
Biotech News 06 Jun 2024 Creating the Right Environment for mRNA To Thrive Explore how the standardization of processes, manufacturing agility and collaboration will help to advance the next generation of therapeutics. The… Pantitra
Biotech News 24 May 2024 Researchers determine mechanism of action of delta inulin, uncover key to more effective vaccines Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new… Pantitra
Biotech News 16 May 2024 New mRNA vaccine for deadly brain cancer triggers a strong immune response COVID-19 vaccine development paves way to a new class of cancer immunotherapy. For the first time, scientists have tested a… Pantitra
Biotech News 15 May 2024 Nanotechnology vaccines could protect against unknown coronaviruses Researchers say nanotechnology could help develop vaccines rapidly in case of a new pandemic. Scientists have developed a new vaccine… Pantitra
Biotech News 02 Apr 2024 Australia’s first purpose-built facility to deliver human challenge trials launches in Melbourne The new facility will accelerate the development of novel medicines and vaccines. Australia’s first clinical trial facility specifically commissioned to… Pantitra
Biotech News 18 Jan 2024 Accelerating Recombinant Protein Vaccine Development WuXi Vaccines describes technologies that hasten the progress from vaccine discovery to commercialization Recombinant protein vaccines, which are obtained by… Pantitra
